Antibodies, Reagents
Total Trials
4
As Lead Sponsor
1
As Collaborator
3
Total Enrollment
1,870
NCT00869726
A Study for Patients With Secondary Progressive Multiple Sclerosis
Phase: Phase 2/3
Role: Collaborator
Start: Dec 31, 2004
Completion: May 31, 2009
NCT00869986
A Study for Patients With Relapsing Remitting Multiple Sclerosis
Start: Nov 30, 2006
Completion: Sep 30, 2009
NCT00870155
A Study for Patients With Multiple Sclerosis
Start: Feb 28, 2007
NCT00468611
Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis
Phase: Phase 3
Role: Lead Sponsor
Start: Jun 30, 2007
Loading map...